Hosted on MSN

Lee’s Pharmaceutical Advances in Cervical Cancer Treatment: A Phase III Study Update

Lee’s Pharmaceutical Holdings Limited ((HK:0950)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, ...
Indiatimes

Continuous night sweats could be an early warning sign of cancer: Understanding symptoms, causes and when to seek medical advice

Persistent night sweats, often dismissed, can be a subtle warning sign for serious health issues, including various cancers. While not always indicative of malignancy, these excessive nighttime ...
ascopubs.org

Challenges and Opportunities in the Treatment of Invasive Cervical Cancer in Low-Resource Settings: A Survey of the International Gynecologic Cancer Society Fellowship Programs

Cervical and Tumor-Associated Microbiomes in Botswana Women With and Without HIV With Carcinoma of the Cervix Before and After Definitive Chemoradiation Patients at IGCS sites experienced significant ...
Business Insider

Minerva Neurosciences Announces Financing of up to $200 Million to Advance Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia Through a Phase 3 ...

Minerva secures $80 million up front and up to an additional $80 million subject to the full exercise of Tranche A warrants. Minerva and the FDA have defined a path forward for roluperidone’s clinical ...